source
- Multispecific antibodies push CDMOs to redesign development platformsManufacturers are moving beyond traditional monoclonal-antibody platforms as multispecific therapeutics gain traction. The new design model relies on molecular engineering, advanced analytics, and…
- FDA alerts on possible Aspergillus contamination in Avid Medical IV start kitsThe FDA’s Center for Devices and Radiological Health has issued an Early Alert warning that certain IV start kits from Avid Medical may be contaminated with the fungus Aspergillus penicillioides, a…